Showing results (1281-1290 of 1,584) with videos related to

Sort By:
Pageof 159
Journal of Virology|February 1, 1997
Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognitionC C Wilson, S A Kalams, B M Wilkes, et al.
Journal of Virology|November 13, 1998
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)F Gao, D L Robertson, C D Carruthers, et al.
Biosafety and Health|May 1, 2023
Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccineQian Chen, Pei Du, Yuxuan Han, et al.
Structure (London, England : 1993)|July 16, 2024
Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variantsLinjie Li, Kaiyuan Shi, Yuhang Gu, et al.
Ebiomedicine|October 18, 2024
Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virusTianxiang Kong, Pei Du, Renyi Ma, et al.
Journal of Virology|June 19, 2015
Newly Emergent Highly Pathogenic H5N9 Subtype Avian Influenza A VirusYang Yu, Xingbo Wang, Tao Jin, et al.
Vaccine|April 26, 2002
Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trialsS M Agwale, C Zeh, K E Robbins, et al.
Med (New York, N.Y.)|April 4, 2024
Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodiesQingwen He, Yaling An, Xuemei Zhou, et al.
Plos Pathogens|September 20, 2024
A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variantsTianjiao Hao, Yulei Li, Peipei Liu, et al.
Cells|December 23, 2022
The Parallel Presentation of Two Functional CTL Epitopes Derived from the O and Asia 1 Serotypes of Foot-and-Mouth Disease Virus and Swine SLA-2*HB01: Implications for Universal Vaccine DevelopmentLei Feng, Yong-Yu Gao, Mingwei Sun, et al.
Pageof 159